InflaRx is a startup based in Germany, most recent round Series-c-plus, 2 tracked investors.
Based in Germany, InflaRx is a startup. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
InflaRx is a clinical-stage biopharmaceutical company developing novel therapeutics to treat life-threatening inflammatory conditions. Their approach involves targeting the complement system.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.